ENTOD Pharma receives DCGI approval for phase 3 trials for myopia eye drop : vimarsana.com

Maharashtra based pharmaceutical company has the highest market share in low dose atropine -- MYATRO 0.01 per cent eye drops -- is used to treat eye problems like myopia, especially in children.

Related Keywords

Maharashtra , India , United States , American , Namrata Sharma , Nikkhilk Masurkar , Entod Pharmaceuticals On , American Academy Of Ophthalmology , India Ophthalmological Society , Drug Controller General , Low Concentration Atropine , Myopia Progression , American Academy , Executive Director , General Secretary , All India Ophthalmological Society , Dose Atropine , Entod Pharma , Cgi Approval , Yopia Eye Drop , Entod Pharmaceuticals , Drug Controller General Of India , Atropine Eye Drops , Eye Problems , Myopia , ,